Michael Mina, MD, PhD, explains Invivyd's accelerated approval path for VYD2311 and how it could change the timing of COVID-19 protection.
|Articles|November 1, 1999
The American Journal of Managed Care
- November 1999
- Volume 5
- Issue 11
The Cost of Medicaid-Covered Services Provided to Disabled Adults with Neurologic Disorders: Implications for Managed Care
Advertisement
Articles in this issue
almost 27 years ago
Doctor, I'm Having a Heart Attack, What Should I Do?almost 27 years ago
Estimates of Costs of Primary Care Physician Turnoveralmost 27 years ago
Paying for HIV/AIDS Care at the Turn of the Centuryalmost 27 years ago
Developing a Managed Care Delivery System for People with HIV/AIDSAdvertisement
Related to this article
The study authors note there is an urgent need for "innovative value-based and alternative payment models of care."
The conference, held in New Orleans, Louisiana, by the American Academy of Ophthalmology, will offer 3 full days of content spanning from glaucoma to dry eye.
A JAMA analysis of 2021-2023 death records found heat-related mortality varied sharply by occupation and industry among working-age US adults.
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Bumetanide nasal spray is bioequivalent to oral bumetanide in 68 healthy adults; Esperion is targeting heart failure care before a 2027 CMS payment model.
The trade group says CMS lacks authority to impose GLOBE, which is set to begin January 1.
Biomarker-driven care is advancing in mantle cell lymphoma, though cost and infrastructure limit access in community oncology, according to a review.
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know if Retatrutide Is Classified as a Biologic
2
Predoc and Nebraska Cancer Specialists: Not Letting the Fax Be the Fumble
3
FDA Approves First Symptomatic Dermographism Treatment
4
Sacral Neuromodulation Still Seen as OAB Gold Standard in Review
5